Statistics from Altmetric.com
Epimacular brachytherapy (EMB) combines pars plana vitrectomy and intraocular delivery of 24 grey irradiation for the treatment of neovascular age-related macular degeneration. We previously compared the projected cost of treatment with EMB, in combination with as required (Pro Re Nata (PRN)) anti-vascular endothelial growth factor (VEGF) therapy, with PRN anti-VEGF monotherapy.1 At that time, phase III trials of EMB were unavailable, and our projections were based on phase II trials.2 ,3 The CABERNET study recently provided phase III data in treatment-naive disease.4 Herein we present updated costs for …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.